evidencegaps
Primary study · included by 1 review

Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.

Jeong 2013 · Jeong Shin Young, Kim Hae Won, Lee Sang-Woo, et al. · Thyroid : official journal of the American Thyroid Association · 2013

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Jeong 2013 · Supplementary Table S3 (included studies); Figs. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · more than 1 year after RIT
Prevalence 0.17 [0.10, 0.28]6 studies · 1005 participantsGRADE not reported

1 including review in total.